Why Kinder Morgan Canada (TSX:KML), Bausch Health (TSX:BHC), and Ceridian HCM (TSX:CDAY) Raced Ahead on the TSX Wednesday

The TSX had a good day Wednesday gaining 0.59%. South of the border, the S&P 500 gained 0.82% on the day while the Dow raced ahead 0.93%.

The markets had a good day Wednesday, as the TSX gained 0.59%, the S&P 500 was up 0.82%, and the Dow gained 0.93%.

Investors continue to debate where interest rates are headed. The minutes from the most recent meeting of the Federal Reserve suggest even they’re not so sure. 

Despite the lack of confidence from investors, these three stocks raced ahead on the TSX Wednesday.

Kinder Morgan Canada 

Kinder Morgan Canada (TSX:KML) jumped 32% Wednesday on the $4.3 billion takeover offer from Pembina Pipeline (TSX:PPL)(NYSE:PBA).

Under the terms of the deal, Pembina will pay 0.3068 of one of its shares for each share of Kinder Morgan Canada. That’s approximately $15.02 per KML share. In addition, Pembina will pay $2.1 billion for the 2,900-kilometre Cochin pipeline that runs from Fort Saskatchewan, Alberta, to Riga, Michigan. 

Kinder Morgan, which owns 70% of Kinder Morgan Canada, will get a stake in Pembina worth $1.2 billion. 

Pembina wouldn’t have done the deal if the U.S. portion of the Cochin pipeline wasn’t included in the purchase. 

“I suspect Pembina was pretty adamant that they do include that and eventually there was enough pressure in the process,” Raymond James analyst Chris Cox said. “The valuation seems fair; they are definitely good assets.”

With Pembina one of the few producers winning on the markets in 2019, the latest news ought to be good for the long-term trajectory of its stock.

Bausch Health

Bausch Health (TSX:BHC)(NYSE:BHC) gained 5.4% on Wednesday closing out trading at $29.83, up 18% year to date through August 21. 

Although there wasn’t any news that would have moved Bausch stock by more than 5% on Wednesday, it’s probably still basking in the glow of strong second-quarter results and increased guidance for the remainder of fiscal 2019. 

“Our strong second-quarter results demonstrate that our team’s efforts to pivot to offence continue to gain traction,” CEO Joseph Papa said on a conference call August 6. 

The company expects to generate at least US$8.4 billion in revenue in 2019 along with US$3.4 billion in adjusted EBITDA. 

Since Papa took over in 2016, the company has focused on reducing its debt while concentrating on growing its “significant seven,” which includes its optical products and treatments for glaucoma and bloodshot eyes. 

Ceridian HCM

Ceridian HCM (TSX:CDAY)(NYSE:CDAY) saw its shares rise 4.3% Wednesday to $75.35. 

Like Bausch Health, Ceridian’s move had less to do with specific news and more to do with its second-quarter earnings report from July 30. 

The company’s Dayforce cloud-based human capital management software continues to capture the interest of more and more businesses around the world. In the second quarter, Dayforce’s revenue grew 27.1% to US$134.5 million. Its Dayforce recurring revenue grew even more impressively, growing by 32.1% year over year excluding currency. 

As a result of its strong start to the fiscal year, the company expects Dayforce to grow revenues by between 29% and 31% in the second half of the year. 

Ceridian’s stock will continue to ride the success of Dayforce. Until its growth slows, expect more impressive quarterly reports in the future.  

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned. The Motley Fool owns shares of Bausch Health Companies and Kinder Morgan. Pembina is a recommendation of Dividend Investor Canada.

More on Investing

A microchip in a circuit board powers artificial intelligence.
Tech Stocks

This Tech Stock Could Dominate the Future of AI and Cybersecurity in Canada

OpenText may come to dominate the cybersecurity arena in Canada.

Read more »

dividends can compound over time
Energy Stocks

1 Magnificent Canadian Energy Stock Due for a Major Rebound

This energy stock isn't going to surge overnight, but it could provide decades of stable income.

Read more »

a man relaxes with his feet on a pile of books
Bank Stocks

1 Canadian Bank Stock That Smart Money Is Buying

A surging Big Bank stock is a smart buy for value and income investors in the second half of 2025.

Read more »

money goes up and down in balance
Dividend Stocks

The Ultimate Value Stock to Buy With $500 Right Now

This TSX stock has a well-established business, solid earnings growth potential, and a valuation that leaves room for significant upside.

Read more »

concept of real estate evaluation
Bank Stocks

1 Magnificent Canadian Financial Stock Down 15 Percent to Buy and Hold for Life

As traditional bank stocks surge higher, this non-prime lender is still catching up. And that’s exactly what makes it interesting…

Read more »

todder holds a gold bar
Metals and Mining Stocks

1 Gold Mining Stock That’s My Inflation Protection Play

Agnico Eagle Mines stock has generated inflation-beating returns over the past decade, and the gold stock retains strong growth momentum

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Dividend Stocks

1 TFSA-Worthy Dividend Stock to Buy and Hold for Life

Bank of Montreal (TSX:BMO) stock seems worth picking up for your TFSA for the long-term dividend growth and decent valuation.

Read more »

investor looks at volatility chart
Dividend Stocks

Why This 4.6% Dividend Stock Could Be Your Best Defence Against Volatility

We're all looking for ways to keep our investments safe and stable, and this one is a great option.

Read more »